Form D · Pharmaceuticals
TPG Valley, L.P.
Fort Worth, TX · CIK 0001663437
Offering snapshot reported Jan 25, 2016 · SEC filing
- Reported sold
- $7.25M Offering amount: $7.25M
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Dec 31, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 25, 2016 | Initial | $7,250,000 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-255871
PROFITS INTERESTS
Source: Form D, filed Jan 25, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Clive Bode | Director, Executive |
| David Bonderman | Executive |
| James G. Coulter | Executive |
| Martin Davidson | Executive |
| David C. Reintjes | Executive |
| John E. Viola | Director, Executive |
| Steven A. Willmann | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
301 Commerce Street Suite 3300, Attn. General Counsel
Fort Worth, TX, 76102
Fort Worth, TX, 76102